additional pharma notes
TRANSCRIPT
-
8/7/2019 additional pharma notes
1/9
THE FIVE PLUS FIVE RIGHTS OF DRUGTHE FIVE PLUS FIVE RIGHTS OF DRUG
ADMINISTRATIONADMINISTRATION
THE RIGHT CLIENTTHE RIGHT CLIENT
Verify client by checking ID bracelet and nametagVerify client by checking ID bracelet and nametag
Ask the client to state his/her nameAsk the client to state his/her name
Have high-lighted warning tools for clients with same last nameHave high-lighted warning tools for clients with same last name
Address the client by name before administering the drugAddress the client by name before administering the drug
Ask for allergiesAsk for allergies
THE RIGHT DRUGTHE RIGHT DRUG
The client receives the drug that was prescribed by a physician,The client receives the drug that was prescribed by a physician,
dentist or any authorized prescriber.dentist or any authorized prescriber.
THE RIGHT DOSETHE RIGHT DOSE
Be familiar with measurement conversion process and drugBe familiar with measurement conversion process and drug
preparation. Calculate the dose correctly.preparation. Calculate the dose correctly.
Check drug reference books for recommended dosage
range
Measure liquid preparation at the lowest part of the
meniscus
THE RIGHT TIMETHE RIGHT TIME
The nurse should adhere as closely as possible t the scheduledThe nurse should adhere as closely as possible t the scheduled
times.times.
Nurses must check whether the client is for surgery or diagnosticNurses must check whether the client is for surgery or diagnosticprocedures and determine the need for withholding theprocedures and determine the need for withholding the
drugsdrugs
Expiration dates must be checkedExpiration dates must be checked
Antibiotics are administered at even intervalsAntibiotics are administered at even intervals
THE RIGHT ROUTETHE RIGHT ROUTE
Be sure to know the prescribed route by which as medication is toBe sure to know the prescribed route by which as medication is to
be administeredbe administered
Assess the clients ability to swallow before the administration ofAssess the clients ability to swallow before the administration of
oral medicationsoral medications
Stay with the client after administering the medications to ensureStay with the client after administering the medications to ensure
intake and to monitor acute effects.intake and to monitor acute effects.
THE RIGHT ASSESSMENTTHE RIGHT ASSESSMENT
Requires that appropriate data is collected before administering theRequires that appropriate data is collected before administering the
medications.medications.
THE RIGHT DOCUMENTATIONTHE RIGHT DOCUMENTATION
Be sure to document the medication and time administered on theBe sure to document the medication and time administered on the
chartchart
Document site location after administration of IM, ID and SQDocument site location after administration of IM, ID and SQ
injectioninjection
THE RIGHT TO EDUCATIONTHE RIGHT TO EDUCATION
The client receive correct and complete information about theThe client receive correct and complete information about the
medication and how it relates to his/her particular situation.medication and how it relates to his/her particular situation.
It requires that the patients have the knowledge to make theIt requires that the patients have the knowledge to make the
decision to take the drug (decision to take the drug (informed consentinformed consent) .) .
THE RIGHT EVALUATIONTHE RIGHT EVALUATION
THE RIGHT TO REFUSETHE RIGHT TO REFUSE
Provide appropriate information and explanation why theProvide appropriate information and explanation why the
medication is ordered.medication is ordered.
Document if the client refuses medication, clients reason andDocument if the client refuses medication, clients reason and
report the refusal to the physicianreport the refusal to the physician
AAUTONOMIC NERVOUS SYSTEMUTONOMIC NERVOUS SYSTEM
NEUROHUMORAL TRANSMISSIONNEUROHUMORAL TRANSMISSION
Parasympathetic Nervous SystemParasympathetic Nervous System
innervates primarily the gastrointestinal tract, eye, heart,innervates primarily the gastrointestinal tract, eye, heart,
respiratory tract, glands, and bladderrespiratory tract, glands, and bladder
uses acetylcholine as preganglionic and postganglionicuses acetylcholine as preganglionic and postganglionic
neurotransmitterneurotransmitter
Muscarinic AgonistsMuscarinic Agonists- produce the same response as that obtained- produce the same response as that obtained
by stimulating the parasympathetic nervous systemby stimulating the parasympathetic nervous system
Acetylcholinesterase-Acetylcholinesterase- produce their pharmacologic action byproduce their pharmacologic action by
blocking the enzymatic hydrolysis of acetylcholineblocking the enzymatic hydrolysis of acetylcholine
Neostigmine, Pyridostigmine, and Edroponium andNeostigmine, Pyridostigmine, and Edroponium and
PhysostigminePhysostigmine
Therapeutic UsesTherapeutic Uses
Pupillary constriction in the treatment of glaucomaPupillary constriction in the treatment of glaucoma
Increase muscle strength in client with myasthenia gravisIncrease muscle strength in client with myasthenia gravis
Reversal of neuromuscular blockadeReversal of neuromuscular blockade
Adverse effectsAdverse effects: Bradycardia, asthma, peptic ulcer: Bradycardia, asthma, peptic ulcer
Nursing ConsiderationsNursing Considerations
Administer IV drug slowlyAdminister IV drug slowlyAdminister with foods BUTAdminister with foods BUT better BEFORE mealsbetter BEFORE meals
MaintainMaintain atropine sulfateatropine sulfate as antidoteas antidote
Discontinue the drug if excessive salivation, diarrhea, vomiting,Discontinue the drug if excessive salivation, diarrhea, vomiting,
and muscle weakness (cholinergic crisis)and muscle weakness (cholinergic crisis)
Muscarinic Blocking Agents-Muscarinic Blocking Agents- competitively block the actions ofcompetitively block the actions of
acetylcholine at both central and peripheral muscarinicacetylcholine at both central and peripheral muscarinic
receptorsreceptors
Atropine, Ipratropium, Scopolamine, and GlycopyrrolateAtropine, Ipratropium, Scopolamine, and Glycopyrrolate
Therapeutic UsesTherapeutic Uses
Pre-op medication to decrease salivary secretions and pupilPre-op medication to decrease salivary secretions and pupil
dilatationdilatation
Anti-spasmodic drug to treat peptic ulcerAnti-spasmodic drug to treat peptic ulcerAgent to increase the heart rate when bradycardia is presentAgent to increase the heart rate when bradycardia is present
Antidote for cholinergic agonists poison (betanAntidote for cholinergic agonists poison (betan
Motion sickness use scopolamineMotion sickness use scopolamine
Asthma use ipratropiumAsthma use ipratropium
Adverse effects:Adverse effects:
Dry mouth, blurred vision, tachycardia, constipation, urinaryDry mouth, blurred vision, tachycardia, constipation, urinary
retentionretention
ContraindicationsContraindications -- Glaucoma, Urinary and GIGlaucoma, Urinary and GIobstruction,obstruction,
ileusileus
Nursing ConsiderationsNursing Considerations
Provide comfort measuresProvide comfort measures
Ensure adequate hydration to prevent hyperpyrexiaEnsure adequate hydration to prevent hyperpyrexiaProtect eyes form lightsProtect eyes form lights
Advise to avoid hazardous activitiesAdvise to avoid hazardous activities
Provide high-fiber diet and laxativeProvide high-fiber diet and laxative
Instruct to void before administering the drugInstruct to void before administering the drug
Sympathetic Nervous SystemSympathetic Nervous System
modulates the activity of smooth muscle, cardiac muscle, andmodulates the activity of smooth muscle, cardiac muscle, and
glandular cellsglandular cells
transfer of information from terminals of most sympathetitransfer of information from terminals of most sympatheti
neurons to the effector organs is mediated by norepinephrineneurons to the effector organs is mediated by norepinephrine
-
8/7/2019 additional pharma notes
2/9
except those few anatomically sympathetic neurons thatexcept those few anatomically sympathetic neurons that
project toproject to sweat glandssweat glands and someand some blood vessels in the neckblood vessels in the neck,,
face, and skeletal musclesface, and skeletal musclesthat use acetylcholine as athat use acetylcholine as a
transmittertransmitter
-Receptors-Receptors- located in the smooth muscle throughout the body ,- located in the smooth muscle throughout the body ,
in the eye, lung, blood vessels (arteries), uterus, gut, andin the eye, lung, blood vessels (arteries), uterus, gut, and
genitourinary systemgenitourinary system
-Receptors-Receptors- located chiefly on the presynaptic nerve terminals- located chiefly on the presynaptic nerve terminalscreate a negative feedback that inhibits NE releasecreate a negative feedback that inhibits NE release
vascular smooth muscle contains postsynaptic -receptorsvascular smooth muscle contains postsynaptic -receptors
that produce vasoconstriction (veins)that produce vasoconstriction (veins)
-Receptors-Receptors- located in the postsynaptic membranes in the heart- located in the postsynaptic membranes in the heart
-Receptors-Receptors- located in smooth muscle and gland cells- located in smooth muscle and gland cells
Direct-acting SympathomimeticsDirect-acting Sympathomimetics
receptor agonists mimic the effects of sympathoadrenal dischargereceptor agonists mimic the effects of sympathoadrenal discharge
by combining directly with postjunctional receptorsby combining directly with postjunctional receptors
Eg: Norepinephrine (Levophed), Epinephrine, DopamineEg: Norepinephrine (Levophed), Epinephrine, Dopamine
(Intropin), Phenylephrine(Intropin), Phenylephrine
EpinephrineEpinephrine (Adrenalin)-(Adrenalin)-increases BP and HR, pupil dilatationincreases BP and HR, pupil dilatation
and bronchodilatationand bronchodilatation
Therapeutic useTherapeutic use: Asthma, Anaphylactic shock and cardiac arrest: Asthma, Anaphylactic shock and cardiac arrest
Adverse reactionAdverse reaction: palpitations, tachycardia and dyspnea. High: palpitations, tachycardia and dyspnea. High
doses can result in cardiac dysrhythmias.doses can result in cardiac dysrhythmias.
Albuterol (Ventolin)Albuterol (Ventolin) - purely bronchodilatation, affect the - purely bronchodilatation, affect the
causing increased in HR at high dosescausing increased in HR at high doses
Clonidine and Methyldopa-Clonidine and Methyldopa- treat hypertension by regulating thetreat hypertension by regulating the
release of nor-epinephrine leading to decreased blood pressurerelease of nor-epinephrine leading to decreased blood pressure
Indirect-acting SympathomimeticsIndirect-acting Sympathomimetics
do not activate receptors directly but facilitate the release ofdo not activate receptors directly but facilitate the release of
norepinephrine from sympathetic neuronal varicosities, ornorepinephrine from sympathetic neuronal varicosities, or
block the reuptake transporter in the neuronal membraneblock the reuptake transporter in the neuronal membrane
Eg. Amphetamine, Ephedrine, PhenylpropanolamineEg. Amphetamine, Ephedrine, Phenylpropanolamine
Therapeutic effectsTherapeutic effects
Vasoconstriction in hypotensionVasoconstriction in hypotension
Attention deficit disorderAttention deficit disorder
NarcolepsyNarcolepsy
Appetite control, obesityAppetite control, obesity
Adverse effectsAdverse effects::
Nausea, tremors, hyperactivity and headacheNausea, tremors, hyperactivity and headache
Mixed acting SympathomimeticsMixed acting Sympathomimetics
stimulate the adrenergic receptor sites and stimulate the release ofstimulate the adrenergic receptor sites and stimulate the release of
nor-epinephrine from terminal nerve endingsnor-epinephrine from terminal nerve endings
Eg: Ephedrine, MetaraminolEg: Ephedrine, Metaraminol
Therapeutic useTherapeutic useHypotension- the drug increases systolic and diastolic BP byHypotension- the drug increases systolic and diastolic BP by
cardiac stimulationcardiac stimulation
Treat mild form of bronchial asthmaTreat mild form of bronchial asthma
Shock (Metaraminol)- It enhances cardiac activity and mildShock (Metaraminol)- It enhances cardiac activity and mild
vasoconstrictionvasoconstriction
Adverse effects:Adverse effects:
tremors, headache, hyperactivity and insomniatremors, headache, hyperactivity and insomnia
Nursing Considerations:Nursing Considerations:
Check for the vital signs and ECGCheck for the vital signs and ECG
Note for adverse effects of adrenergic drugsNote for adverse effects of adrenergic drugs
Check the IV insertion site for any tissue necrosisCheck the IV insertion site for any tissue necrosis
SympatholyticsSympatholytics
inhibits the synthesis, storage, or release of norepinephrineinhibits the synthesis, storage, or release of norepinephrine
-Adrenergic Receptor Antagonists-Adrenergic Receptor Antagonists -inhibits-inhibits
the contraction of arterial and venousthe contraction of arterial and venous smooth musclesmooth muscle
eg: Prazosin (Minipress), Terazosin (Hytrin)eg: Prazosin (Minipress), Terazosin (Hytrin)
-Adrenergic Receptor Antagonists-Adrenergic Receptor Antagonists
-involved in advocating sympathetic output-involved in advocating sympathetic output
-decrease vagal tone-decrease vagal tone
-delays platelet aggregation-delays platelet aggregation
-facilitating the release of NE and Ach-facilitating the release of NE and Ach from nervefrom nerve
endingsendings
-promotion of insulin secretion and-promotion of insulin secretion and initiationinitiation
of lipolysisof lipolysis
eg: Yohimbineeg: Yohimbine
Therapeutic UsesTherapeutic Uses
Hypertension= prompt vasodilatation which causes decreased BPHypertension= prompt vasodilatation which causes decreased BP
Decrease the symptoms of benign prostatic hypertrophyDecrease the symptoms of benign prostatic hypertrophyPeripheral vascular disease (Raynauds disease) vasodilatationPeripheral vascular disease (Raynauds disease) vasodilatation
increase the blood flow to the extremitiesincrease the blood flow to the extremities
Adverse effects: reflex tachycardia and orthostatic hypotensionAdverse effects: reflex tachycardia and orthostatic hypotension
Nursing considerationNursing consideration
Monitor heart rate and BPMonitor heart rate and BP
Caution to change position slowlyCaution to change position slowly
Advise to avoid hazardous activitiesAdvise to avoid hazardous activities
Provide supportive measures like quiet environment, rest andProvide supportive measures like quiet environment, rest and
analgesicsanalgesics
Monitor response to the drug improvement of blood pressureMonitor response to the drug improvement of blood pressure
readings and urinationreadings and urination
Selective -Adrenergic AntagonistsSelective -Adrenergic Antagonists -therapeutic effects-therapeutic effects
are on theare on the cardiovascularcardiovascular system by slowing thesystem by slowing the
heart rate and decreasing myocardialheart rate and decreasing myocardialcontractilitycontractility
eg: Metoprolol, atenolol, esmolol,eg: Metoprolol, atenolol, esmolol,
acebutolol, betaxololacebutolol, betaxolol
Nonselective -Adrenergic AntagonistNonselective -Adrenergic Antagonist
- block the -adrenergic receptor of the heart and the- block the -adrenergic receptor of the heart and the
-adrenergic receptor in bronchial smooth muscle-adrenergic receptor in bronchial smooth muscle
(bronchoconstriction)(bronchoconstriction)
eg: Propranolol (Inderal), Nadolol, Timolol,eg: Propranolol (Inderal), Nadolol, Timolol,
Pindolol, LabetololPindolol, Labetolol
Therapeutic UsesTherapeutic Uses
HypertensionHypertension
Glaucoma= it decreases the secretion of aqueous humorGlaucoma= it decreases the secretion of aqueous humor
Migraine= induces vasodilatation in brain vasculatureMigraine= induces vasodilatation in brain vasculature
HyperthyroidismHyperthyroidism
Angina and Myocardial infarction= reduces the chest pain uponAngina and Myocardial infarction= reduces the chest pain upon
exertionexertion
Contraindications (Non selective)Contraindications (Non selective)AllergyAllergy
Heart blocksHeart blocks
BradycardiaBradycardia
COPDCOPD
CHFCHF
Adverse effectsAdverse effects
CVS- bradycardiaCVS- bradycardia,, hypotension,hypotension, heart blockheart block
CNS- fatigue, dizziness, unsteadinessCNS- fatigue, dizziness, unsteadiness
Respi- bronchospasm, pulmonary edemaRespi- bronchospasm, pulmonary edema
GI- nausea, vomiting, diarrhea, hypoglycemiaGI- nausea, vomiting, diarrhea, hypoglycemia
-
8/7/2019 additional pharma notes
3/9
GU- decreased libido, impotence, dysuriaGU- decreased libido, impotence, dysuria
Nursing ConsiderationsNursing Considerations
Emphasize NOT to stop abruptly the drug intakeEmphasize NOT to stop abruptly the drug intake
Give with FOODS to improve absorptionGive with FOODS to improve absorption
Provide comfort measuresProvide comfort measures
Adequate rest periodsAdequate rest periods
Avoidance of hazardous activitiesAvoidance of hazardous activities
Change position slowlyChange position slowlyCNS STIMULANTSCNS STIMULANTS
Stimulate the cortical and reticular activating system (RAS) of theStimulate the cortical and reticular activating system (RAS) of the
brain releasing neurotransmitters from the nerve cellsbrain releasing neurotransmitters from the nerve cells
leading to increased stimulation of the post-synapticleading to increased stimulation of the post-synaptic
neurons.neurons.
These are drugs used to treat certain disordersThese are drugs used to treat certain disorders
Exogenous obesity-Exogenous obesity-DextroamphetamineDextroamphetamine
Attention-deficit hyperactivity disorders-Attention-deficit hyperactivity disorders-MethylphenidateMethylphenidate
Narcolepsy-Narcolepsy- ModafinilModafinil
ContraindicationsContraindications
Marked anxiety, agitation, extreme tension, severe tension andMarked anxiety, agitation, extreme tension, severe tension and
glaucoma- exacerbated by the CNS stimulation.glaucoma- exacerbated by the CNS stimulation.
Adverse EffectsAdverse Effects
CNS=CNS= nervousness, insomnianervousness, insomnia, headache, and blurred vision, headache, and blurred vision
GIT=GIT= anorexiaanorexia , nausea and, nausea and weight lossweight lossCVS= HPN,CVS= HPN,tachycardia,tachycardia, arrhythmias, and anginaarrhythmias, and angina
Nursing ConsiderationsNursing Considerations
Administer the drugAdminister the drug before 6 pm to reduce the effect of insomniabefore 6 pm to reduce the effect of insomnia
BEST given AFTER meals to prevent the effect of anorexiaBEST given AFTER meals to prevent the effect of anorexia
Provide safety measures such as side-rails and assisted ambulationProvide safety measures such as side-rails and assisted ambulation
ANTIEPILEPTICSANTIEPILEPTICS
Affect theAffect the entire brainentire brain and reduce the chance of sudden electricaland reduce the chance of sudden electrical
outburst that causes seizuresoutburst that causes seizures
Agents for treatingAgents for treatingTONIC-CLONIC SEIZURESTONIC-CLONIC SEIZURES
Hydantoins (Phenytoin)Hydantoins (Phenytoin)
Benzodiazepines (Diazepam, Clonazepam)Benzodiazepines (Diazepam, Clonazepam)
Barbiturates (Phenobarbital)Barbiturates (Phenobarbital)
Agents for treatingAgents for treating
ABSENCE SEIZURESABSENCE SEIZURES
Succinimides (Ethosuximide)Succinimides (Ethosuximide)
Valproic AcidValproic Acid
ZosinamideZosinamide
Agents for treatingAgents for treatingPartial FOCAL SEIZURESPartial FOCAL SEIZURES
CarbamazepineCarbamazepine
GabapentinGabapentin
HYDANTOINSHYDANTOINS
STABILIZE the nerve cell membrane throughout the brainSTABILIZE the nerve cell membrane throughout the brain
reducing and limiting the excitability and conductionreducing and limiting the excitability and conduction
through nerve pathways.through nerve pathways.
Clinical UsesClinical Uses
Tonic-clonic seizures andTonic-clonic seizures andStatus epilepticusStatus epilepticus
Prevention of seizures in neurosurgeryPrevention of seizures in neurosurgery
Muscle relaxationMuscle relaxation
Adverse effectsAdverse effects
CNS effects- depression, confusion, drowsiness, lethargy, fatigueCNS effects- depression, confusion, drowsiness, lethargy, fatigue
GIT- GINGIVAL HYPERPLASIA and severe liver toxicity whichGIT- GINGIVAL HYPERPLASIA and severe liver toxicity which
are all related to cellular toxicity.are all related to cellular toxicity.
SKIN- hirsutism and coarsening of the facial skinSKIN- hirsutism and coarsening of the facial skin
Bone Marrow depressionBone Marrow depression
Nursing ConsiderationsNursing Considerations
Administer the drug with food to alleviate GI irritationAdminister the drug with food to alleviate GI irritation
Provide meticulous mouth oral careProvide meticulous mouth oral care
ANTIPARKINSONSANTIPARKINSONS
Enhance the effects of DOPAMINE by promoting dopamineEnhance the effects of DOPAMINE by promoting dopamine
production or by activating the dopamine receptors in the brainproduction or by activating the dopamine receptors in the brain
Eg: Levodopa, Bromocriptine, Amantadine, Pergolide,Eg: Levodopa, Bromocriptine, Amantadine, Pergolide,
SelegilineSelegiline
Precautions:Precautions:
Renal and hepatic disordersRenal and hepatic disordersPsychosisPsychosis
Interactions:Interactions:
Alcohol and Phenytoin will decrease the effect of levodopaAlcohol and Phenytoin will decrease the effect of levodopa
MAOIs can cause hypertensive crisisMAOIs can cause hypertensive crisis
FOOD interactions:FOOD interactions:
With HIGH proteinsWith HIGH proteins
Impair drug transport to the brainImpair drug transport to the brain
With PYRIDOXINE (Vitamin B6)With PYRIDOXINE (Vitamin B6)
These can cause DECREASED effectiveness of the drugThese can cause DECREASED effectiveness of the drug
Exaggerate the drug reactionsExaggerate the drug reactions
-
8/7/2019 additional pharma notes
4/9
1. Therapeutic class: anti-inflammatory agents
a. type: non-steroidal anti-inflammatory agents
b. type: steroidal anti-inflammatory agents
i. action: powerful suppression of inflammation by inhibiting the mobilization leukocytes,fibroblasts, and inflammatory mediators, prevents increased capillary permeability
ii. examples
short-acting
o hydrocortisone (Hydrocortone 20-240 mg by mouth daily in
divided doses)
o hydrocortisone sodium succinate (Solu-Cortef 20-120 mg/m2 IV
every 12-24 hours)
intermediate-acting: predniSONE (Deltasone 5-60 mg by mouth daily in 1-4
doses)
long-acting: dexamethasone (Decadron 0.75-90 mg/kg by mouth daily every
6-12 hours, IV 1-6 mg every 2-6 hours for 72 hours)iii. uses
gold standard for anti-inflammatory action
septic shock, allergy, neoplasms, cerebral edema
inflammatory diseases such as RA, severe COPD
iv. adverse effects
suppression of hypothalamic-pituitary-adrenal axis
opportunistic infections, hyperglycemia, hemorrhage, gastritis, HTN,
thromboembolic disorders, edema
emotional lability, seizures, insomnia
osteoporosis, poor wound healing, fragile skin
hidden infection: client may not display expected findings associated withinfection including fever and leukocytosis
v. contraindications
active infection, psychosis
children < 2 years-old, AIDS, TB
idiopathic thrombocytopenia, acute glomerulonephritis
vi. nursing care
establish baseline data and monitor
o occult infection
o serum glucose, potassium, cortisol level, WBCs
-
8/7/2019 additional pharma notes
5/9
-
8/7/2019 additional pharma notes
6/9
o ameliorate allergic response during invasive procedures using
contrast medium
adverse effects
o anaphylaxis, thrombocytopenia, hemolytic anemia
o drowsiness, poor coordination
o blurred vision, dry mouth, urinary retention, seizures
o nightmares when used as hypnotic, especially with older clients
contraindications: acute asthma
nursing care
o establish baseline data and monitor breath sounds and respiratory
secretions, temperature, level of consciousness
o assist for ambulation
o do not confuse with dimenhyDRINATE
o client teaching
1. may take with food
2. drink 2000 ml fluids daily
3. use sunscreen, ask for help when getting up4. avoid alcohol, OTC drugs, CNS depressants
5. do not drive or engage in hazardous activities
b. second generation (associated with less drowsiness and anticholinergic effects)
c. type: mast cell stabilizers
3. Therapeutic class: immune modulators, stimulants
a. type:interferonsi. action: prevent viral replication in host cells, stimulate production of antiviral proteins,
inhibits tumor growth, and increases aggressiveness of phagocytes
ii. examples
interferon beta-1a (Avonex)
interferon alfa-n 1 lymphoblastoid (Wellferon)
interferon alfa-2a/interferon alfa-2b (Roferon-A)
iii. uses: chronic hepatitis C, malignant melanoma, Kaposis sarcoma, leukemia in clients >
18 years-old
iv. adverse effects
myelosuppression, seizures, MI, heart failure, edema, blood pressure
changes
flushing, photosensitivity, flu-like symptoms
GI upset, weight loss, xerostomia, impotence
v. nursing care
establish baseline data and monitor
o vital signs, EKG, breath sounds: very frequently
o CBC, weight
o bleeding, oral mucosa, mental status
avoid contact with skin
clients may become hemodynamically unstable during therapy
different interferons are not interchangeable: each has individual indications,
dosing, and administration guidelines
administer at bedtime with acetaminophen
administration
o given subcutaneously, IM, and intralesional
o reconstitute and mix gently, solution may be stored for 30 days
o only by qualified personnel, in controlled conditions, wearinggown, gloves, and mask
client teaching
o avoid hazardous activity
o report signs of infection
b. type:interleukins(IL)
i. action: stimulates cellular immunity ofhelper T cellto inhibit tumor growth acts on lymphocytes to stimulate mitogenesis and cytotoxicity initiateskiller
T cell
-
8/7/2019 additional pharma notes
7/9
activity and interferon- production
ii. examples
aldesleukin (IL-2, interleukin-2)
oprelvekin (Neumega)
iii. uses
renal cell carcinoma, melanoma
in combination with zidovudine for HIV
iv. adverse effects
MI, cardiopulmonary arrest, capillary leak syndrome, CVA,
myelosuppression, pulmonary edema, intestinal perforation or ileus,
renal dysfunction
muscle and joint pain, change in mood and mental status, dizziness, impaired
motor function
v. contraindications: abnormal thallium stress test, pulmonary function test, organ allografts
vi. nursing care
establish baseline data and monitor
o continuous blood pressure, EKG, SaO2, PAP, RAP
o RFT, urine output, LFT, bleeding, acidosis
o CBC, differential, platelets; maintain platelets > 75,000/mm3 and
leukocytes > 2,000/ mm3
o clients may become hemodynamically unstable during therapy
do not confuse with Prokine
may store unused solution in refrigerator within 48 hours, do not freeze
administration
o do not shake
o infuse over 15 minutes without inline filter in plastic IV bag
o be prepared to administer
1. hydrocortisone for extravasation2. DOPamine for blood pressure support
client teaching
o report changes in breathing, cough
o watch for infection avoid pregnancy
o avoid shaving, aspirin, ibuprofen, alcohol
c. type: T- and B-cell modulator
i. action: stimulates B-cells leading to increased antibody formation which enhances T-cell,monocyte, andmacrophageactivity
ii. example: levamisole (Ergamisol)iii. use: colon cancer in combination with fluorouracil
iv. adverse effects
myelosuppression
GI upset, taste perversions, alopecia
flu-like symptoms, dizziness, headache
v. nursing care
establish baseline data and monitor CBC and differential
avoid concurrent administration of phenytoin or alcohol
client teaching
o avoid pregnancy
o injection technique
4. Therapeutic class: immune modulators, immunosuppressants
a. information common to immunosuppressive agents
i. action: impair an aspect of the immune system most responsible for or likely to stimulateallograftrejection while exposing the individual to risks of immunosuppression
ii. adverse effects
susceptibility to opportunistic infections and malignancies, masks signs of
infection, stimulates latent infection
nephrotoxicity, hepatic dysfunction, hyperglycemia, hyperlipidemia,
thrombocytopenia, dysrhythmias, embryotoxic and teratogenic
anorexia, nausea, diarrhea
potentiates the action and adverse effects of other immunosuppressants
-
8/7/2019 additional pharma notes
8/9
iii. contraindications: when risk of immunosuppression outweighs benefit of drug; tolerance
iv. nursing care
establish baseline data and monitor
o drug levels, RFT, LFT, CBC, immune markers, tissue biopsy,
CXR
o allograft function
1. cardiac: cardiac output, blood pressure, EKG, PAP,
PCWP2. pulmonary: SaO2, PaCO2, PFT3. renal: creatinine, creatinine clearance
4. hepatic: bilirubin, ALT, AST, prothrombin time
o search for infection
o client teaching
1. need for follow-up care and testing
2. avoid pregnancy, promptly report signs of infection
3. follow manufactures instructions on mixing andadministration, take only as directed, and take until
instructed to stop
4. hand-washing and infection control
1. wear tight fitting mask on windy days2. cook meat, poultry, and fish until well-done
3. avoid sick people, ceiling fans and room
fans
4. avoid digging in dirt, cat litter box, birds andbird cages
5. restrict fresh fruits and vegetables to items
that are easily peeled or washed in soap and
water such as bananas, oranges, apples,
carrots, tomatoes, potatoes
b. type: T- and B-cell suppressants
i. action: suppress antibody production, suppressor and helper T-cells, and release of
interleukins
ii. examples:
cyclosporine (Sandimmune, Neoral)
mycophenolate mofetil (CellCept)
sirolimus (Rapamune) (macrolide)
tacrolimus (Prograf)
iii. uses:
prevention and treatment of transplant allograft rejection in combination with
other immunosuppressants and glucocorticoids
prevention of allograft vasculopathy
autoimmune disorders, non-Hodgkins lymphoma, Crohns disease
-
8/7/2019 additional pharma notes
9/9
adverse effects
lower risk of hyperlipidemia with tacrolimus (Prograf)
iv. nursing care
c. type: monoclonal antibodiesi. action: impairs the effects of tumor necrosis factor alpha, competes with IL-2 for receptor
sites, and impairs immunological response to antigens
ii. examples
muromonab-CD3 (Orthoclone OKT3)
basiliximab (Simulect)
infliximab (Remicade)
iii. uses
prevention and treatment of transplant allograft rejection in combination with
other immunosuppressants and glucocorticoids
Crohns disease, rheumatoid arthritis
iv. adverse effects
increased susceptibility to infection, heart failure, anaphylaxis, pulmonary
edema, hemodynamic instability
GI upset, bleeding, gingival hyperplasia
fever, chills, headache, insomnia, muscle and joint pain
impaired metabolism of uric acid, K+, Ca++, P
v. nursing care
establish baseline data and monitor
o drug levels
o RFT, LFT, CBC, CXR, hidden infection
o cardiac allograft: cardiac output, blood pressure, EKG, PAP,
PCWP
o pulmonary allograft: SaO2, PaCO2, PFT
o renal allograft: creatinine, creatinine clearance
o hepatic allograft: bilirubin, ALT, AST, prothrombin time
vi. administration
oral route preferred
IV: reconstitute by gently inverting 50 ml bag of 5% dextrose or 0.9% NaCl,
do not shake
vii. client teaching
avoid pregnancy
promptly report signs of infection
need for follow-up care and testing
hand-washing and infection control
wear tight fitting mask on windy days
cook meat, poultry, and fish until well-done
avoid sick people, ceiling fans and room fans
restrict fresh fruits and vegetables to items that are easily peeled or washed in
soap and water such as bananas, oranges, apples, carrots, tomatoes, potatoes
avoid digging in dirt, cat litter box, birds and bird cages
d. type: glucocorticoids
used in combination with cyclosporine and other immunosuppressants